Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 40,159 | 35,064 | 38,894 | 34,376 | 30,408 |
| Cost of Goods | 15,598 | 14,887 | 15,258 | 13,099 | 10,663 |
| Gross Profit | 24,561 | 20,177 | 23,636 | 21,277 | 19,745 |
| Operating Expenses | 26,050 | 23,421 | 22,577 | 18,479 | 16,597 |
| Operating Income | -891 | -2,357 | 1,317 | 2,897 | 3,811 |
| Interest Expense | 647 | 590 | 492 | 441 | 433 |
| Other Income | 137 | -356 | -381 | -381 | -111 |
| Pre-tax Income | -1,401 | -3,303 | 444 | 2,075 | 3,267 |
| Income Tax | -699 | -1,145 | 1,609 | 655 | 597 |
| Net Income Continuous | -702 | -2,158 | -1,165 | 1,420 | 2,670 |
| Minority Interests | -104 | -137 | N/A | N/A | N/A |
| Net Income | $-598 | $-2,021 | $-1,191 | $1,420 | $2,670 |
| EPS Basic Total Ops | 0.00 | -0.02 | N/A | 0.00 | N/A |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.06 | 0.01 | 0.08 |
| EPS Diluted Total Ops | 0.00 | -0.02 | N/A | 0.00 | N/A |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.05 | 0.01 | 0.07 |
| EBITDA(a) | $663 | $-887 | $2,002 | $3,086 | $4,012 |